Exploiting the extemporaneousness of radiopharmaceuticals: Radiolabeling stability under diverse conditions
- 29 August 2022
- journal article
- conference paper
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 221, 115024
Abstract
No abstract availableKeywords
Funding Information
- Comissão Nacional de Energia Nuclear (01341.011064/2021-71)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/010.000981/2019)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/200.815/2021)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (301069/2018-2)
This publication has 17 references indexed in Scilit:
- Modern Radiopharmaceutical Dosimetry Should Include Robust Biodistribution ReportingJournal of Nuclear Medicine, 2018
- Radiopharmaceutical tracers for cardiac imagingJournal of Nuclear Cardiology, 2017
- 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate CancerSeminars in Nuclear Medicine, 2016
- Detection of breast cancer microcalcification using 99mTc-MDP SPECT or Osteosense 750EX FMT imagingNuclear Medicine and Biology, 2015
- Radiochemical purity testing of 99mTc-labelled radiopharmaceuticalsNuclear Medicine Communications, 2011
- Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomographyApplied Radiation and Isotopes, 2009
- Procedure Guideline for the Use of Radiopharmaceuticals 4.0Journal of Nuclear Medicine Technology, 2007
- Qualitätskontrolle von Radiopharmaka: Beachtenswerte BesonderheitenPharmazie in unserer Zeit, 2005
- Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPAEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988